Development and Validation of a Risk Score System for Early Prediction of Venous Thromboembolism in Patients with Lung Cancer

The data collected included: patient identification (medical record number, year of hospitalization), demographic and clinicopathological data (age, gender, BMI, WHO status, smoking, hypertension, diabetes, dyslipidemia, coronary artery disease, heart failure, surgical history), biological data(blood cell count (White blood cells, Hemoglobin, Platelets), C-reactive Protein (CRP), creatinine), lung cancer data (stage of disease, histological type, TNM classification, length of follow-up, surgical treatment, chemotherapy, the regimen of chemotherapy (platinum-based chemotherapy), radiation), VTE data (occurrence of PE, the occurrence of DVT, the occurrence of DVT, time to onset of VTE).